Pfizer Plans to Release COVID-19 Pill by the End of 2021
Pfizer CEO Albert Bourla, DVM, PhD, announced on April 27 that the company hopes to release an at-home, oral drug designed to inhibit the enzymes that SARS-CoV-2 requires to reproduce in human cells. Pfizer began testing of the antiviral…